1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
LaMeditech Co. Ltd.

LaMeditech Co. Ltd.

KKRX:462510
2,865.00
KRW
+120.00
(+4.37%)
-1,108.64EPS
23.64BMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
412.53
535.88
816.23
821.36
632.08
Basic EPS, GAAP
-889
-1,525
-1,177
-1,299
-1,108.64
Free Cash Flow per Basic Share
-742.85
-719.11
-1,761.54
-1,752.38
-1,406.95
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
-1,358.61
988.51
2,214.16
956.5
557.04
Tangible Book Value per Share
-1,361.69
985.1
2,174.06
912.4
510.52
Basic Weighted Avg Shares
5
5
8
9
9
Sales/Revenue/Turnover
2,056
2,918
6,577
7,187
5,561
Operating Margin (%)
-162.65
-120.82
-146.9
-164.78
-194.36
Depreciation Expense
235
296
465
595
610
Net Income, GAAP
-4,430
-8,305
-9,484
-11,367
-9,754
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
-215.5
-284.58
-144.2
-158.15
-175.4
Working Capital
-12,454
7,526
14,204
6,668
41
LT Debt
1,089
820
602
4,483
1,404
Total Equity
-11,753
8,551
19,154
8,420
4,904
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-68.46
-82.45
-102.23

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,821
2,996
6,162
LT Borrowings
4,400
4,360
1,320
LT Finance Leases
83
95
84
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
58,012
40,142
23,636

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
16,898
13,800
11,366
Cash, Cash Equivalents & STI
8,554
5,579
3,753
Accounts Receivable, Net
874
1,163
1,071
Inventories
4,548
4,971
5,497
Total Current Liabilities
10,230
9,794
11,324
Payables & Accruals
- -
- -
- -
ST Debt
2,821
2,996
6,162
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-56.04%
Free Cash Flow
- -
- -
8.04%
Net Income, GAAP
- -
- -
19.86%
Sales/Revenue/Turnover
- -
- -
9.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
979
1,858
1,693
2,047
6,577
2025
1,925
1,650
1,758
1,854
7,187
2026
815
1,134
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-188.16
-376
-269
-321.37
-1,177
2025
-318
-294
-343.69
-342.51
-1,299
2026
-328.98
-94
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jong-Seok Choi
Full Time Employees
68
Sector
Health technology
Industry
Medical specialties
Address
#1002, ACE HighEnd Tower Seoul SL South Korea
IPO Date
Jun 17, 2024
Website
lameditech.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
LAMEDITECH Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. The company offers laser lancing devices under the HandyRay-Lite and HandyRay brands for personal and small clinic use; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a 308nm excimer light system for treating various human skin diseases; and Ray-Vet, a UVB light irradiation therapy system for inflammatory skin diseases and auto-immune conditions in pets and animals. Founded in 2012 and headquartered at #1002, ACE High-End Tower, 234 Beotkkot-ro, Geumcheon-gu, Seoul, South Korea, LAMEDITECH operates primarily in the healthcare equipment sector with a focus on laser miniaturization technology for medical, beauty, and veterinary applications. The company serves domestic and international markets including the U.S., Japan, and the E.U., listing its shares on the KOSDAQ exchange under ticker 462510 in June 2024.